Trilogy Capital’s WisdomTree Emerging Markets Multifactor Fund EMMF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$70.5M Sell
1,824,236
-61,357
-3% -$2.28M 2.74% 7
2026
Q1
$62.4M Buy
1,885,593
+99,540
+6% +$3.38M 2.75% 7
2025
Q4
$56.3M Buy
1,786,053
+27,070
+2% +$847K 2.52% 7
2025
Q3
$53.8M Sell
1,758,983
-3,812
-0.2% -$113K 2.49% 12
2025
Q2
$50.9M Buy
1,762,795
+44,122
+3% +$1.21M 2.47% 11
2025
Q1
$45.6M Buy
1,718,673
+1,113,796
+184% +$29.7M 2.39% 11
2024
Q4
$16.2M Buy
604,877
+2,823
+0.5% +$77.8K 0.83% 34
2024
Q3
$17.1M Buy
602,054
+6,047
+1% +$168K 0.86% 33
2024
Q2
$16.5M Sell
596,007
-15,936
-3% -$427K 0.9% 33
2024
Q1
$16.1M Buy
+611,943
New +$15.5M 0.93% 31

Other funds holding EMMF

Trilogy Capital's EMMF Position: Q2 2026 in Review

Trilogy Capital reduced its WisdomTree Emerging Markets Multifactor Fund (EMMF) stake by 3.3% in Q2 2026, selling an estimated $2.28M and leaving 1,824,236 shares worth $70.5M. The position accounts for 2.74% of the portfolio, ranked #7.

Trilogy Capital first reported a position in EMMF in Q1 2024 and has held it in 10 quarters since. 14 funds tracked by Wall St. Rank hold EMMF as of Q2 2026.

  • Trilogy Capital held 1,824,236 shares of WisdomTree Emerging Markets Multifactor Fund worth $70.5M as of Q2 2026.
  • Trilogy Capital sold 61,357 WisdomTree Emerging Markets Multifactor Fund shares in Q2 2026, an estimated $2.28M.
  • WisdomTree Emerging Markets Multifactor Fund made up 2.74% of Trilogy Capital's portfolio in Q2 2026, its #7 holding.
  • Trilogy Capital first reported a position in WisdomTree Emerging Markets Multifactor Fund in Q1 2024 and has held it in 10 quarters since.
  • 14 funds tracked by Wall St. Rank held WisdomTree Emerging Markets Multifactor Fund as of Q2 2026.

Based on Trilogy Capital's 13F filing for Q2 2026, filed 6 Jul 2026.